Oral Mucositis Treatment Market 2034: EMA, PDMA, FDA Approvals, Medication, NICE Approvals, Clinical Trials, Revenue, Statistics, Therapies, Prevalence, Companies by DelveInsight

(Albany, USA) DelveInsight's "Oral Mucositis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Oral Mucositis, historical and forecasted epidemiology as well as the Oral Mucositis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Oral Mucositis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Oral Mucositis pipeline products will significantly revolutionize the Oral Mucositis market dynamics.

The Key Oral Mucositis Companies in the market include - Swedish Orphan Biovitrum, Galera Therapeutics, EpicentRx, Galera Therapeutics, Inc., Soligenix, Monopar Therapeutics, MitoImmune Therapeutics, and others.

To Know in detail about the Oral Mucositis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Oral Mucositis Market Forecast -https://www.delveinsight.com/sample-request/oral-mucositis-om-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of the key facts of the Oral Mucositis Market Report:
• The Oral Mucositis market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
• In April 2025, Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") announced that Jaguar family company Napo Pharmaceuticals ("Napo") is exhibiting at the 50th anniversary Oncology Nursing Society (ONS) Congress taking place April 9-13, 2025 in Denver, Colorado as part of ongoing commercial activities for Gelclair. "We have expanded our footprint beyond HIV-related supportive care to include cancer-related supportive care, and our recent in-licensing of the FDA-approved oral mucositis product Gelclair is a first building block," said Lisa Conte, Jaguar's president and CEO.
• In November 2024, Dusquetide, the active compound in SGX945 (for Behçet's Disease) and SGX942 (for oral mucositis), belongs to a novel class of short, synthetic peptides known as innate defense regulators (IDRs). These agents work through a unique mechanism that adjusts the body's response to injury and infection, promoting anti-inflammatory, anti-infective, and tissue-repairing effects. Unlike antibiotics, IDRs do not directly kill bacteria; instead, they enhance the body's innate immune response, improving survival rates following infections from a wide range of Gram-positive and Gram-negative pathogens. Dusquetide has shown a favorable safety and tolerability profile in a Phase 1 trial involving 84 healthy volunteers. Furthermore, Phase 2 and 3 trials in more than 350 patients undergoing chemoradiation for head and neck cancer revealed promising efficacy in treating oral mucositis, along with potential long-term health benefits.
• In May 2024, Soligenix is a late-stage biopharmaceutical company dedicated to developing and commercializing treatments for rare diseases that currently lack effective options. Our Specialized BioTherapeutics division is advancing HyBryteTM (SGX301 or synthetic hypericin sodium), a novel photodynamic therapy that uses safe visible light to treat cutaneous T-cell lymphoma (CTCL). Following the successful completion of the second Phase 3 study, we plan to seek regulatory approvals for potential global commercialization. Additionally, this division is working on expanding the use of synthetic hypericin (SGX302) for psoriasis, our first-in-class innate defense regulator (IDR) technology, dusquetide (SGX942) for treating inflammatory diseases such as oral mucositis in head and neck cancer, and SGX945 for Behçet's Disease.
• Increasing Incidence of cancer and emerging therapies, will fuel the Oral Mucositis market
• Oral mucositis refers to erythematous and ulcerative lesions of the oral mucosa observed in patients with cancer being treated with chemotherapy, and/or with radiation therapy to fields involving the oral cavity
• According to Claudio et al., about 40% of the patients treated with chemotherapy develop
• mucositis; this percentage rises to about 90% for head and neck cancer patients (HNC) treated with both chemo- and radiotherapy
• According to the analysis, the prevalence of oral mucositis ranges from 30% to 40% among the general cancer patient population.
• Key Oral Mucositis Companies: Swedish Orphan Biovitrum, Galera Therapeutics, EpicentRx, Galera Therapeutics, Inc., Soligenix, Monopar Therapeutics, MitoImmune Therapeutics, and others
• Key Oral Mucositis Therapies: KEPIVANCE (palifermin), Avasopasem manganese (GC4419), RRx-001, Avasopasem Manganese (GC4419), SGX942, Validive (Clonidine HCl), MIT-001, and others
• The Oral Mucositis epidemiology based on gender analyzed that a significantly greater risk of OM has been found in women than in men (86% vs. 60%), and their Oral Mucositis generally is more severe and lasts longer

Oral Mucositis Overview
Oral Mucositis is a common and painful side effect experienced by patients undergoing cancer treatments such as chemotherapy and radiotherapy. Oral Mucositis leads to inflammation and ulceration of the mucous membranes in the mouth, significantly impacting a patient's quality of life. Oral Mucositis symptoms typically include redness, swelling, pain, and the formation of painful sores, making eating, drinking, and speaking difficult.
Oral Mucositis pathophysiology involves damage to the rapidly dividing epithelial cells of the oral mucosa, leading to mucosal barrier injury. Oral Mucositis risk factors include the type and intensity of cancer treatment, poor oral hygiene, and pre-existing oral conditions. Oral Mucositis diagnosis is often clinical, based on visual examination and patient-reported symptoms.
Oral Mucositis treatment focuses on pain management, maintaining oral hygiene, and using therapeutic agents like mouth rinses, protective coatings, and low-level laser therapy. Oral Mucositis prevention strategies include cryotherapy, good oral care routines, and prophylactic treatments before starting cancer therapy. Oral Mucositis management plays a crucial role in ensuring patient compliance with cancer treatment and improving overall outcomes.
Oral Mucositis research is advancing, with newer therapies being developed to minimize its impact. Oral Mucositis awareness is essential for early intervention and optimal care in oncology settings.

Get a Free sample for the Oral Mucositis Market Report: https://www.delveinsight.com/report-store/oral-mucositis-om-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Oral Mucositis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Oral Mucositis Epidemiology Segmentation:
The Oral Mucositis market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Oral Mucositis
• Prevalent Cases of Oral Mucositis by severity
• Gender-specific Prevalence of Oral Mucositis
• Diagnosed Cases of Episodic and Chronic Oral Mucositis

Download the report to understand which factors are driving Oral Mucositis epidemiology trends @ Oral Mucositis Epidemiological Insights - https://www.delveinsight.com/sample-request/oral-mucositis-om-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Oral Mucositis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Oral Mucositis market or expected to get launched during the study period. The analysis covers Oral Mucositis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Oral Mucositis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Oral Mucositis Therapies and Key Companies
• KEPIVANCE (palifermin): Swedish Orphan Biovitrum
• Avasopasem manganese (GC4419): Galera Therapeutics
• RRx-001: EpicentRx
• Avasopasem Manganese (GC4419): Galera Therapeutics, Inc.
• SGX942: Soligenix
• Validive (Clonidine HCl): Monopar Therapeutics
• MIT-001: MitoImmune Therapeutics

To know more about Oral Mucositis treatment, visit @ Oral Mucositis Medications - https://www.delveinsight.com/sample-request/oral-mucositis-om-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Scope of the Oral Mucositis Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Oral Mucositis Companies: Swedish Orphan Biovitrum, Galera Therapeutics, EpicentRx, Galera Therapeutics, Inc., Soligenix, Monopar Therapeutics, MitoImmune Therapeutics, and others
• Key Oral Mucositis Therapies: KEPIVANCE (palifermin), Avasopasem manganese (GC4419), RRx-001, Avasopasem Manganese (GC4419), SGX942, Validive (Clonidine HCl), MIT-001, and others
• Oral Mucositis Therapeutic Assessment: Oral Mucositis current marketed and Oral Mucositis emerging therapies
• Oral Mucositis Market Dynamics: Oral Mucositis market drivers and Oral Mucositis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Oral Mucositis Unmet Needs, KOL's views, Analyst's views, Oral Mucositis Market Access and Reimbursement

To know more about Oral Mucositis companies working in the treatment market, visit @ Oral Mucositis Clinical Trials and Therapeutic Assessment - https://www.delveinsight.com/sample-request/oral-mucositis-om-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents
1. Oral Mucositis Market Report Introduction
2. Executive Summary for Oral Mucositis
3. SWOT analysis of Oral Mucositis
4. Oral Mucositis Patient Share (%) Overview at a Glance
5. Oral Mucositis Market Overview at a Glance
6. Oral Mucositis Disease Background and Overview
7. Oral Mucositis Epidemiology and Patient Population
8. Country-Specific Patient Population of Oral Mucositis
9. Oral Mucositis Current Treatment and Medical Practices
10. Oral Mucositis Unmet Needs
11. Oral Mucositis Emerging Therapies
12. Oral Mucositis Market Outlook
13. Country-Wise Oral Mucositis Market Analysis (2020-2034)
14. Oral Mucositis Market Access and Reimbursement of Therapies
15. Oral Mucositis Market Drivers
16. Oral Mucositis Market Barriers
17. Oral Mucositis Appendix
18. Oral Mucositis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Trending Reports:
• Absssi Market Size: https://www.delveinsight.com/report-store/acute-bacterial-skin-and-skin-structure-infection-absssi-market-insights-epidemiology-and-market-forecast
• Acquired Immunodeficiency Syndrome Market: https://www.delveinsight.com/report-store/acquired-immunodeficiency-syndrome-aids-market
• Actinic Keratosis Market: https://www.delveinsight.com/infographics/actinic-keratosis-market
• Acute Intermittent Porphyria Market: https://www.delveinsight.com/report-store/acute-intermittent-porphyria-market
• Ashermans Syndrome Market: https://www.delveinsight.com/report-store/ashermans-syndrome-market
• Bacterial Skin Diseases Market: https://www.delveinsight.com/report-store/acute-bacterial-skin-and-skin-structure-infections-market
• Biliary Stents Market: https://www.delveinsight.com/report-store/biliary-stents-market
• Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market
• Bone Densitometers Market: https://www.delveinsight.com/blog/bone-densitometers-market-analysis
• Carpal Tunnel Syndrome Market: https://www.delveinsight.com/report-store/carpal-tunnel-release-system-market
• Diabetic Neuropathy Market: https://www.delveinsight.com/report-store/diabetic-peripheral-neuropathy-market
• Duchenne Muscular Dystrophy Market: https://www.delveinsight.com/blog/duchenne-muscular-dystrophy-market
• Eczema Market: https://www.delveinsight.com/report-store/eczema-market
• Exocrine Pancreatic Insufficiency Market: https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-epi-market
• Head And Neck Squamous Cell Carcinoma Market: https://www.delveinsight.com/report-store/head-and-neck-cancer-hnc-market
• Hemodynamic Monitoring Systems Market: https://www.delveinsight.com/report-store/hemodynamic-monitoring-system-market
• Hepatitis B Virus Market: https://www.delveinsight.com/report-store/chronic-hepatitis-b-virus-market
• Implantable Infusion Pumps Market: https://www.delveinsight.com/report-store/implantable-infusion-pumps-market
• Multiple Myeloma Market: https://www.delveinsight.com/report-store/multiple-myeloma-market
• Pharma Competitive Intelligence: https://www.delveinsight.com/blog/competitive-intelligence-in-healthcare-sector
• Precocious Puberty Market: https://www.delveinsight.com/report-store/precocious-puberty-market
• Walking Impairment In Multiple Sclerosis Market: https://www.delveinsight.com/report-store/walking-impairment-in-multiple-sclerosis-market
• Anaphylaxis Market: https://www.delveinsight.com/report-store/anaphylaxis-market
• Biochips Market: https://www.delveinsight.com/blog/biochips-market-landscape
• Central Venous Catheters Market: https://www.delveinsight.com/report-store/central-venous-catheters-market
• Contraceptive Devices Market: https://www.delveinsight.com/report-store/contraceptive-devices-market
• Diabetic Foot Ulcers Dfus Market: https://www.delveinsight.com/infographics/diabetic-foot-ulcers-dfus-market
• Hearing Aid Devices Market: https://www.delveinsight.com/report-store/audiology-devices-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Intracranial Pressure Monitoring Devices Market: https://www.delveinsight.com/report-store/intracranial-pressure-monitoring-devices-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Ophthalmic Imaging Equipment Market: https://www.delveinsight.com/report-store/ophthalmic-imaging-equipment-market
• Osteoarthritis Market: https://www.delveinsight.com/report-store/knee-osteoarthritis-market
• Pruritus Market: https://www.delveinsight.com/report-store/chronic-pruritus-market
• Surgical Stapling Devices Market: https://www.delveinsight.com/report-store/surgical-stapling-devices-market
• Wound Closure Devices Market: https://www.delveinsight.com/report-store/wound-closure-device-market
• Apheresis Market: https://www.delveinsight.com/report-store/apheresis-market
• Arteriovenous Fistula Market: https://www.delveinsight.com/report-store/arteriovenous-fistula-market
• Atypical Teratoid Rhabdoid Tumors Market: https://www.delveinsight.com/report-store/atypical-teratoid-rhabdoid-tumors-atrt-epidemiology-forecast
• Bladder Cancer Market: https://www.delveinsight.com/report-store/non-muscle-invasive-bladder-cancer-market
• Catheter-related Bloodstream Infections Market: https://www.delveinsight.com/report-store/catheter-related-bloodstream-infection-market
• Central Pain Syndrome Market: https://www.delveinsight.com/report-store/central-pain-syndrome-market
• Fibrocystic Breast Condition Market: https://www.delveinsight.com/report-store/fibrocystic-breast-condition-epidemiology-forecast
• Global Electrophysiology Devices Market: https://www.delveinsight.com/report-store/electrophysiology-devices-market
• Interbody Cages Market: https://www.delveinsight.com/report-store/interbody-cages-market
• Neurostimulation Devices Market: https://www.delveinsight.com/report-store/neurostimulation-devices-market
• Nsclc Market: https://www.delveinsight.com/report-store/non-small-cell-lung-cancer-nsclc-market
• Palmar Hyperhidrosis Market: https://www.delveinsight.com/report-store/palmar-hyperhidrosis-market
• Palmar Hyperhidrosis Market Size: https://www.delveinsight.com/report-store/palmar-hyperhidrosis-market
• Pressure Ulcers Market: https://www.delveinsight.com/report-store/pressure-ulcers-market
• Allergic Rhinitis Market: https://www.delveinsight.com/report-store/allergic-rhinitis-market
• Anti-cd274 Pd-l1 Antibody Pipeline: https://www.delveinsight.com/report-store/pd-1-and-pd-l1-inhibitors-competitive-landscape
• Arthroscopy Devices Market: https://www.delveinsight.com/report-store/arthroscopy-devices-market
• Cervical Intraepithelial Neoplasia Market: https://www.delveinsight.com/report-store/cervical-cancer-market
• Cough Assisted Device Market: https://www.delveinsight.com/report-store/cough-assist-devices-market
• Foot And Ankle Devices Market: https://www.delveinsight.com/report-store/foot-and-ankle-devices-market
• Minimal Residual Disease Market: https://www.delveinsight.com/report-store/minimal-residual-disease-market
• Pharma Licensing Services: https://www.delveinsight.com/consulting/licensing-services
• X Linked Hypophosphatemia Market: https://www.delveinsight.com/report-store/x-linked-hypophosphatemia-market
• Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market
• Androgenetic Alopecia Market: https://www.delveinsight.com/report-store/androgenetic-alopecia-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Image Guided Surgery Devices Market: https://www.delveinsight.com/report-store/image-guided-surgery-devices-market
• Non Alcoholic Fatty Liver Disease Nafld Market: https://www.delveinsight.com/report-store/non-alcoholic-fatty-liver-disease-nafld-market
• Artificial Kidney Market: https://www.delveinsight.com/report-store/artificial-kidney-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Healthcare Due Diligence Services: https://www.delveinsight.com/consulting/due-diligence-services
• Hearing Implants Market: https://www.delveinsight.com/report-store/hearing-implants-market
• Pulse Oximeter Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Radioligand Therapies Market: https://www.delveinsight.com/report-store/radioligand-therapies-market-forecast
• Continuous Renal Replacement Therapy Machines Market: https://www.delveinsight.com/report-store/continuous-renal-replacement-therapy-machines-market
• Dysthymia Market: https://www.delveinsight.com/report-store/major-depressive-disorder-market
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market
• Menopause Market: https://www.delveinsight.com/report-store/menopause-market-forecast
• Prefilled Syringes Market: https://www.delveinsight.com/report-store/prefilled-syringes-market
• Gaucher Disease Market: https://www.delveinsight.com/report-store/gauchers-disease-market
• Healthcare Competitive Benchmarking: https://www.delveinsight.com/consulting/competitive-benchmarking-services
• Healthcare Subscription Models: https://www.delveinsight.com/blog/subscription-model-in-healthcare
• Wound Irrigation Systems Market: https://www.delveinsight.com/report-store/wound-irrigation-systems-market
• Benefits Of Robotics In Healthcare: https://www.delveinsight.com/blog/robotics-in-healthcare
• Adamantinoma Market: https://www.delveinsight.com/blog/bone-cancer-treatment-market
• Trigeminal Neuralgia Market Size: https://www.delveinsight.com/report-store/chronic-pain-market
• Xerostomia Market: https://www.delveinsight.com/report-store/xerostomia-pipeline-insight
• Abetalipoproteinemia Market: https://www.delveinsight.com/report-store/abetalipoproteinemia-market
• Astigmatism Market: https://www.delveinsight.com/report-store/astigmatism-market
• Calcinosis Cutis Market: https://www.delveinsight.com/report-store/calcinosis-cutis-market
• Cardiotoxicity Market: https://www.delveinsight.com/report-store/cardiotoxicity-market
• Molecular Glue Market: https://www.delveinsight.com/report-store/molecular-glues-market-forecast
• Pneumoconiosis Market: https://www.delveinsight.com/report-store/pneumoconiosis-market
• Polypoidal Choroidal Vasculopathy Market: https://www.delveinsight.com/report-store/polypoidal-choroidal-vasculopathy-market
• Sts Devices Market: https://www.delveinsight.com/report-store/sts-devices-market

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/ats-conference-coverage

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.